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Abstract a-Oxidation of 3-methyl-substituted fatty acids was 
studied in purified rat liver peroxisomes. The experiments 
revealed that formyl-CoA is formed during the a-oxidation 
process. The amount of formyl-CoA found constituted 2-5% of 
the amount of formate formed. Under the conditions used, no 
activation of exogenously added formate occurred in purified 
peroxisomes, whereas 95.5% of added synthetic formyl-CoA was 
converted to formate. These data indicate that during a-
oxidation first formyl-CoA is formed, which is then hydrolysed 
to formate. 
© 1997 Federation of European Biochemical Societies. 
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We, therefore, investigated whether formyl-CoA is formed 
during a-oxidation in purified peroxisomes, using the syn-
thetic 3-methyl[l-14C]hexadecanoic acid (3-methyl[l-14C]-
palmitic acid) as a substrate [4,14]. 
2. Materials and methods 
2.1. Materials 
Sodium [14C]formate was from New England Nuclear. Unlabelled 
and l-14C-labelled (specific radioactivity 58.5 Ci/mol) 3-methylpal-
mitic acid were synthesized as described before [8]. Vivaspin 15 ml 
concentrators (cut off 10000 Da) were obtained from Sipan (Lier, 
Belgium). 
1. Introduction 
3-Methyl-substituted fatty acids cannot undergo peroxiso-
mal ß-oxidation because of the presence of a methyl group in 
the 3-position. They first have to be shortened by one carbon 
atom via a-oxidation resulting in 2-methyl-substituted fatty 
acids [1], that are substrates for peroxisomal ß-oxidation [2-
6]. Degradation of phytanic acid, a 3-methyl-branched fatty 
acid [1], and of synthetic 3-methyl-branched fatty acids [4] is 
deficient in Refsum's disease and in disorders of peroxisome 
biogenesis, which leads in these disorders to progressive accu-
mulation of phytanic acid. Mihalik et al. [7] and Croes et al. 
[8] have recently demonstrated that in rat liver a-oxidation is 
a peroxisomal process. Casteels, Croes, Van Veldhoven and 
Mannaer ts (submitted) have demonstrated this for human liv-
er as well, which classifies Refsum's disease as a peroxisomal 
disorder. Mihalik et al. [7] and Croes et al. [8] have also 
shown that the first step of a-oxidation is an activation reac-
tion, which is followed by a 2-hydroxylation [8] and they were 
able to identify a 2-hydroxy-3-methylacyl-CoA intermediate 
[7,8]. As shown first by Poulos et al. in human fibroblasts 
[9] and later by Casteels et al. [10] in isolated rat hepatocytes, 
besides CO2 also formate is produced by a-oxidation. It has 
recently been demonstrated by Croes et al. [8] that formate is 
in fact the primary end-product that is rapidly converted to 
C 0 2 . The reactions starting from the 2-hydroxy-3-methylacyl-
CoA intermediate and leading to the production of formate 
remain largely unknown. 
Considering the fact that a 2-hydroxy-3-methylacyl-CoA 
intermediate and formate are formed, one may expect form-
yl-CoA to be generated in an intermediary step. As far as we 
know, however, the existence of formyl-CoA has up to now 
only been described in microorganisms [11-13]. 
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2.2. Synthesis of formyl-CoA 
For the synthesis of unlabelled and 14C-labelled formyl-CoA, the 
reaction scheme of Rajgarhia et al. [15] for activation of acetate and 
propionate was followed, but the reaction volumes were doubled and 
the concentration of dichlorobenzoic acid was increased as this was 
required for a good solubilization of the formic acid. 
Briefly, 20 umol unlabelled or 14C-labelled formate, sodium salt 
(0.23 Ci/mol) was dried in a 25 ml glass round-bottom flask over 
P2O5 for 48 h. Dichlorobenzoic acid (80 umol) in dry tetrahydrofuran 
(1 ml) was added and the flask was sealed with a stopper and para-
film. The mixture was stirred with a magnetic stirrer at 65°C for 90 
min. The reaction mixture was cooled to room temperature before the 
addition of l,r-carbonyldiimidazole (40 umol) in dry tetrahydrofuran 
(1 ml) and was stirred at 65°C for another 90 min. The reaction 
mixture was cooled to room temperature. CoA (25 umol) in aqueous 
imidazole buffer (1.6 ml, 0.5 M, pH 7.0) was added and the reaction 
mixture stirred at room temperature for 15 min. After acidification 
(pH 3), the solvent was evaporated under N2 on ice. [
14C]Formic acid, 
likely to escape during evaporation, was trapped in 1 N NaOH. Dur-
ing the further purification the solution containing formyl-CoA was 
kept on ice or at 4°C at all times except when mentioned otherwise. 
The formyl-CoA was purified by isocratic elution monitored by radio-
activity and/or UV-absorbance at 254 nm from an Econosphere Cig 
preparative column (Alltech, 250X22 mm, 10 urn, 80 A) with aceto-
nitrile/potassium phosphate buffer (50 mM, pH 5.5), 5/95 (v/v), at 
room temperature (flow rate was 5.0 ml/min). The formyl-CoA frac-
tions were collected, acidified to pH 3 and pooled. To obtain a con-
centrated formyl-CoA solution in a low ionic strength medium, the 
acetonitrile (rotovap, 25-30°C) was removed and the salt solution 
containing formyl-CoA was applied at 4°C on an activated Ci8 
SPE-column (Varian, 500 mg), equilibrated with 15 ml of potassium 
phosphate buffer (50 mM, pH 3). Formyl-CoA was eluted with 2 ml 
of potassium phosphate buffer (10 mM, pH 3)/acetonitrile (1:9, v/v) 
and 2 ml of methanol. The formyl-CoA fractions were collected and 
evaporated to dryness under N2 on ice. The residue was reconstituted 
in 400 ul of distilled water in order to obtain a solution of formyl-
CoA in potassium phosphate buffer (5 mM, pH 3) and stored at 
—20°C until use. Spectral analysis of the formyl-CoA, performed 
directly after purification, was in accordance with its structure (ab-
sorbance maximum at 260 nm (adenine group); ratio A233/A260 = 0.54 
(thioester)). 
2.3. Animals 
The experiments were performed with overnight-fasted male Wistar 
rats weighing 200-250 g. 
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2.4. Preparation and incubation of purified per oxisomes 
A light mitochondrial fraction of rat liver was prepared in 0.25 M 
sucrose containing 0.1% (v/v) ethanol and 5 mM 3-(7V-morpholino)-
propanesulfonic acid (pH 7.2) [16] and subfractionated by centrifuga-
tion through an iso-osmotic self-generating Percoll gradient as de-
scribed before [8]. The gradient was collected in 30 fractions of 
equal volume starting from the bottom and the fractions containing 
the peroxisomes were pooled and diluted approximately 10-fold with 
the sucrose medium. After centrifugation for 20 min at 16200Xg in a 
conical tube, the supernatant was removed and the peroxisomes were 
resuspended in 3 ml of sucrose medium. Incubations (37°C) were 
started by adding 100 JLLI of the purified peroxisomes (0.5-1.1 mg 
protein) to 400 ul of reaction medium. Final concentrations were 
100 mM KC1, 50 mM Tris (pH 7.5), 0.025 mM defatted bovine serum 
albumin, 4 mM ATP, 2.4 mM MgCl2, 0.2 mM CoA, 0.1 mM FeCl2, 
3 mM 2-oxoglutarate and 10 mM L-ascorbate. Substrate concentra-
tions were 0.05 mM 3-methyl[l-14C]palmitate (specific radioactivity 
58.5 Ci/mol), 0.025 mM [14C]formate (specific radioactivity 5 Ci/ 
mol) and 0.2 mM [14C]formyl-CoA (specific radioactivity 0.23 Ci/ 
mol). Reactions were terminated after 10 min by acidification to pH 
3 by addition of 50 ill of potassium phosphate (1 M, pH 2) and the 
reaction vials were immediately placed in ice water. 
2.5. Analysis of the reaction medium for [uCJformyl-CoA 
After termination of the reaction, the reaction mixtures of duplicate 
samples were collected in an Eppendorf tube and centrifuged at 
12 000 X g for 10 min at 4°C. The supernatant was filtered through 
a Vivaspin concentrator (cut off 10000 Da) by centrifugation at 
1000 X g for 90 min at 4°C. Filtrates were kept at -20°C until 
HPLC analysis the following day. 
Unlabelled formyl-CoA (50 nmol in 7 ul) was added as a carrier to 
750 ul of the filtrate (450 ul for 3-methyl[l-14C]palmitate as a sub-
strate), 700 ul (400 ul) of which was injected onto a Nova-Pak Qg 
HPLC column (3.9 X 150 mm, 4 urn, 60 À). 
Formate, CoA and formyl-CoA were separated with a gradient of 
acetonitrile in potassium phosphate buffer (50 mM, pH 5.5): 100% 
phosphate buffer for 3 min; linear increase 0-2% acetonitrile in 1 min; 
isocratic 2% acetonitrile in phosphate buffer for 26 min. Flow rate was 
1.0 ml/min. 
Column effluents were monitored by using an on-line UV-detector 
set at 254 nm. Radioactivity was monitored after the UV-detector by 
using a radioactivity detector connected in series (for incubations with 
3-methyl[l-14C]palmitate) as described before [8], or (for the other 
substrates with lower specific radioactivity) by collection of the frac-
tions and liquid scintillation counting. Counting efficiency of the on-
line detector was approximately 50%. 
2.6. Determination of [liC]formate on column effluents 
Purified peroxisomes were incubated for 10 min with 3-methyl-
[l-14C]palmitate and incubation mixtures analysed as described above. 
Column effluents were collected in fractions of 1 ml after passing 
the UV-detector. Of each fraction, 400 ul was counted as such after 
addition of 4 ml of Hionic Fluor (Wallac 1410 liquid scintillation 
counter, Pharmacia). Another aliquot of 400 ul was transferred to a 
weighed reaction vial, alkalinised with NaOH (pH-12) and kept in the 
oven at 70°C for 3 h to evaporate the acetonitrile and hydrolyse any 
esters present. After acidification (pH-3) with HC1, the volume was 
reconstituted to 750 ul and formate was determined as described 
before [8]. A [14C]formate standard was taken along to determine 
the recovery. Recovery of [14C]formate from [14C]formyl-CoA was 
evaluated by using the synthesized [14C]formyl-CoA standard and 
was comparable to the recovery of the formate standard (85%). 
3. Results and discussion 
In contrast to Sly et al. [11], we found that formyl-CoA is 
relatively stable at p H 3, but hydrolyses quickly at a p H 
above 5.5 even if kept at 4°C (Fig. 1). Therefore, incubations 
were terminated by acidification to p H 3 and reaction mix-
tures were kept on ice or at 4°C at all times after termination 
of the reaction, except during the actual H P L C analysis. 
When purified peroxisomes were incubated with 3-methyl-
[l-1 4C]palmitate, H P L C analysis of the filtrate of the incuba-
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Fig. 1. Stability of formyl-CoA in function of pH. The degradation 
of formyl-CoA was measured over a pH range of 3-8.5. 20 nmol of 
synthetic [14C]formyl-CoA were injected onto the HPLC after 5 (o) 
and 24 h (•) at 4°C in 50 mM of one of the following buffers: po-
tassium phosphate (pH 3 and 6.5), potassium acetate (pH 4.5), 
2-(JV-morpholino)ethane-sulphonic acid (pH 5.5), Tris (pH 7.5) and 
Hepes (pH 8.5). Results are expressed as the % of formyl-CoA in a 
control sample injected at time 0. 
tion medium revealed three 14C-labelled peaks at approxi-
mately 2 min, 16 min and 27 min, respectively (Fig. 2). The 
first and the second peak coeluted with a formate and a form-
yl-CoA standard, respectively. Although difficult to see due to 
the low concentrations, the second and the third peak seemed 
to show a UV-absorbance at 254 nm and were alkali-sensitive. 
When the H P L C fractions were collected, hydrolysed and 
analysed for [14C]formate, the counts of the first and second 
14C-labelled peak were recovered as formate (Fig. 3), confirm-
ing their identity as formate and formyl-CoA, respectively. 
However, no counts were recovered for the third peak (Fig. 
3), suggesting the presence of an ester with a 14C-labelled 
compound other than formate. The peak did not coelute 
with an acetyl-CoA standard (result not shown). The identity 
of this peak remains unknown at present. The amount of 
formate formed was 0.92 ±0 .12 nmol/min per mg protein 
(mean ± SE, n = A). Formyl-CoA and the unidentified com-
pound both constituted 2 - 5 % of the amount of formate. 
To exclude the possibility that the formyl-CoA results from 
an activation of the formate produced during oc-oxidation, 
purified peroxisomes were incubated with exogenously added 
[14C]formate in the presence of the cofactors required for cc-
oxidation. N o [14C]formyl-CoA could be detected (results not 
shown), indicating that formate is not activated in peroxi-
somes. In contrast, when synthetic [14C]formyl-CoA was in-
cubated under these conditions with purified peroxisomes on 
the one hand and sucrose medium as a control on the other 
hand, 95.5% and 40.3% were recovered as [14C]formate, re-
spectively. Although before the incubation 20% of the label 
was present as formate (probably due to hydrolysis of formyl-
CoA during storage), these results clearly demonstrate that 
K. Croes et al.lFEBS Letters 407 (1997) 197-200 199 
formyl-CoA is partly further hydrolysed due to the incubation 
conditions (37°C, p H 7.5), but that the major part of the 
formyl-CoA is actively converted to formate in peroxisomes, 
suggesting the presence of a formyl-CoA hydrolase (or CoA-
transferase?) in rat liver peroxisomes. As far as we know, this 
is the first report on the presence in mammalian tissues of a 
formyl-CoA hydrolase, which up till now has been described 
only in microorganisms [11]. 
In conclusion, we found evidence that formyl-CoA is 
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Fig. 2. HPLC analysis of the reaction medium after incubation of 
purified peroxisomes with 3-methyl[l-14C]palmitate. Purified peroxi-
somes were incubated for 0 min (panels A and B) and 10 min (pan-
el C) with 3-methyl[l-14C]palmitate under a-oxidation conditions. 
After termination of the reaction by acidification, the reaction me-
dium was ultracentrifuged and the supernatant filtered through a 
10000 Da concentrator. An aliquot of the filtrate was analysed for 
[14C]formyl-CoA by HPLC. HPLC effluents were monitored using 
an on-line UV-detector set at 254 nm and a radioactivity detector 
connected in series. Panels B,C: 45 nmol unlabelled formyl-CoA 
was added as a carrier. Each panel shows the radioactivity (trace a) 
and the UV-absorbance at 254 nm (A254) (trace b). The radioactiv-
ity signal is delayed by about 0.2 min relative to the UV-signal. The 
numbered arrows indicate the elution of the following compounds: 
1, CoA; 2, formyl-CoA; 3, formate and 4, unknown compound. 
ELUTION TIME (min) 
Fig. 3. Determination of formate on the HPLC effluents of the reac-
tion medium after incubation of purified peroxisomes with 3-meth-
yl[l-14C]palmitate. Purified peroxisomes were incubated for 10 min 
with 3-methyl[l-14C]palmitate under a-oxidation conditions and an-
alysed by HPLC for formation of formyl-CoA as described in the 
legend to Fig. 2. HPLC effluents were collected after passing the 
UV-detector in fractions of 1 ml. Of each fraction, 400 ju.1 was 
counted for radioactivity as such (panel a, full line) and another 
400 |il was subjected to alkaline hydrolysis and after acidification 
used for the determination of formate (panel a, dashed line). Panel 
b shows the UV-signal at 254 nm (A254). Arrows are numbered as 
for Fig. 2. 
formed during a-oxidation of 3-methyl-substituted fatty acids 
in purified peroxisomes. The major part of formyl-CoA is 
actively converted to formate and the amount of formyl-
CoA found constitutes only 2 - 5 % of the amount of formate. 
The formyl-CoA formed is not due to activation of formate 
— until now presumed to be the primary end-product of oc-
oxidation — but is rather than formate the end-product of oc-
oxidation. This makes it likely that the second end-product, 
the produced 2-methylbranched compound, is a fatty alde-
hyde rather than a fatty acid, as is generally believed [1], 
An additional peak eluting later than formyl-CoA was seen, 
but contained no formate ester. Its nature remains unknown. 
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